Skip to main content
. 2019 May 11;8(5):659. doi: 10.3390/jcm8050659

Figure 2.

Figure 2

Expression of CXCL9 and CCL20 before (pre-PCI) and 3 h after coronary reperfusion by PCI (post-PCI) in patients with MI (n = 39–50) compared to normal controls (healthy volunteers in our laboratory) (n = 11). CXCL9 and CCL20 were measured by ELISA. (A) Expression of CXCL9 in normal controls and patients with MI. (B) Serum CXCL9 levels post-PCI in patients with MI remained more elevated than pre-PCI. (C) Serum CCL20 levels in normal controls and patients with MI. (D) Serum CCL20 levels change significantly after PCI. (E) Serum TNF-α levels in normal controls and patients with MI. (F) Serum TNF-α levels did not change significantly after PCI; (G) Serum TGF-β levels in normal controls and patients with MI. (H) Serum TGF-β levels in post-PCI MI patients remained more elevated than pre-PCI. ELISA = enzyme-linked immunosorbent assay; MI = myocardial infarction; TGF-β = transforming growth factor-β; TNF-α = tumor necrosis factor-α; PCI = percutaneous coronary intervention. Results are presented as mean ± SEM.